← Back to all trials
Active Not Recruiting
NCT03575832
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
Conditions: Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 64
Sponsor: M.D. Anderson Cancer Center
Location: Harris Health System (LBJ) Houston Texas
Summary
This pilot trial studies how well Watchful Living works in improving quality of life in participants with prostate cancer that has not spread to other parts of the body who are on active surveillance and their partners. A social support lifestyle intervention (called Watchful Living) may help African American prostate cancer participants and their partners improve their quality of life, physical activity, diet, and inflammation.
Eligibility Criteria
Inclusion Criteria:
* Self-identify as black or African American or Hispanic (patient)
* Be greater than 18 years of age (patient and spouse or intimate partner)
* Have 0-III stage prostate cancer (patient)
* If treated, have completed therapy (e.g., surgery, chemo and/or radiation) (patient)
* Enroll with a spouse or intimate partner (patient)
* Do not meet physical activity recommendation (i.e., 150 minutes of moderate intensity physical activity per week) (patient and spouse or intimate partner)
* Be ready and able to be physically active, as determined by a physician (letter from a physician or nurse practitioner) (patient and spouse or intimate partner)
* Not participate in another physical activity, diet, or lifestyle program (patient)
* Have a valid home address and telephone number (patient)
* Internet access at home or other location (e.g., work, church, library, community center, etc.) (spouse or intimate partner)
* Patients on active surveillance will be included
Exclusion Criteria:
* They have an active noncutaneous malignancy at any site (patient)
* Had prior radiation therapy for treatment of the primary tumor (patient)
* Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period (patient)
* Are enrolled in another active surveillance protocol (patient)
* Participated in formative focus groups for this study (patient and spouse or intimate partner)
Source: ClinicalTrials.gov (NCT03575832). StuddyBuddy aggregates publicly available trial information.